Siriporn C Chattipakorn Selected Research

Mitochondrial Diseases (Mitochondrial Disease)

10/2022	Modulation of mitochondrial dynamics rescues cognitive function in rats with 'doxorubicin-induced chemobrain' via mitigation of mitochondrial dysfunction and neuroinflammation.
6/2022	Pharmacological Targeting of Mitochondrial Fission and Fusion Alleviates Cognitive Impairment and Brain Pathologies in Pre-diabetic Rats.
6/2022	Not only metformin, but also D-allulose, alleviates metabolic disturbance and cognitive decline in prediabetic rats.
2/2022	CoenzymeQ10 and Ischemic Preconditioning Potentially Prevent Tourniquet-Induced Ischemia/Reperfusion in Knee Arthroplasty, but Combined Pretreatment Possibly Neutralizes Their Beneficial Effects.
1/2022	Sexual dimorphism in cardiometabolic and cardiac mitochondrial function in obese rats following sex hormone deprivation.
11/2021	Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis.
10/2021	Possible roles of mitochondrial dysfunction in neuropathy.
6/2021	D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats.
1/2021	Donepezil attenuated cardiac ischemia/reperfusion injury through balancing mitochondrial dynamics, mitophagy, and autophagy.
1/2021	Hyperbaric oxygen therapy effectively alleviates D-galactose-induced-age-related cardiac dysfunction via attenuating mitochondrial dysfunction in pre-diabetic rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siriporn C Chattipakorn Research Topics

Disease

67	Mitochondrial Diseases (Mitochondrial Disease) 10/2022 - 08/2012
53	Insulin Resistance 10/2022 - 03/2011
42	Inflammation (Inflammations) 10/2022 - 11/2015
32	Cognitive Dysfunction 06/2022 - 10/2014
32	Reperfusion Injury 05/2022 - 01/2015
30	Obesity 04/2022 - 01/2014
28	Ischemia 08/2022 - 01/2015
27	Iron Overload 01/2022 - 03/2013
22	Infarction (Infarctions) 05/2022 - 05/2013
18	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 07/2013
17	Left Ventricular Dysfunction 05/2022 - 01/2015
17	Cardiac Arrhythmias (Arrythmia) 05/2022 - 01/2013
16	Neoplasms (Cancer) 10/2022 - 02/2015
12	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2015
11	Dysbiosis 01/2022 - 01/2017
10	Heart Failure 01/2022 - 01/2015
10	Cardiotoxicity 01/2022 - 01/2020
10	Myocardial Infarction 10/2021 - 01/2016
10	Body Weight (Weight, Body) 06/2021 - 11/2011
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2015
9	Thalassemia 01/2021 - 01/2015
8	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2010
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2015
7	Type 2 Diabetes Mellitus (MODY) 07/2021 - 01/2012
6	Neuroinflammatory Diseases 10/2022 - 01/2021
5	Prediabetic State (Prediabetes) 10/2022 - 01/2020
5	Pain (Aches) 02/2022 - 04/2018
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2013
5	Fibrosis (Cirrhosis) 10/2017 - 06/2015
4	Encephalitis (Encephalitis, Rasmussen) 08/2022 - 01/2016
4	Osteoporosis 02/2022 - 10/2019
4	Stroke (Strokes) 11/2020 - 01/2019
4	Hyperglycemia 01/2020 - 08/2017
3	Chemotherapy-Related Cognitive Impairment 10/2022 - 01/2020
3	Hemochromatosis (Bronze Diabetes) 01/2022 - 01/2018
3	Bone Resorption 01/2022 - 01/2014
3	Atrial Fibrillation 01/2022 - 02/2016
3	Heart Diseases (Heart Disease) 11/2021 - 01/2015
3	Infections 11/2021 - 10/2019
3	Brain Ischemia (Cerebral Ischemia) 08/2021 - 11/2020
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
3	Brain Injuries (Brain Injury) 01/2021 - 10/2020
3	Ventricular Fibrillation 01/2020 - 05/2013

Drug/Important Bio-Agent (IBA)

44	Insulin (Novolin)FDA Link 06/2022 - 03/2011
25	IronIBA 01/2022 - 03/2013
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
19	Metformin (Glucophage)FDA LinkGeneric 06/2022 - 08/2012
16	VildagliptinIBA 01/2018 - 08/2012
15	Estrogens (Estrogen)FDA Link 01/2022 - 11/2011
13	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2015
13	Testosterone (Sustanon)FDA Link 12/2020 - 01/2015
11	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2020
10	salicylhydroxamic acid (SHAM)IBA 08/2022 - 01/2015
10	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2012
10	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 10/2014
9	Pharmaceutical PreparationsIBA 10/2022 - 01/2012
9	CytokinesIBA 05/2022 - 12/2014
9	Chelating AgentsIBA 01/2022 - 01/2016
9	fibroblast growth factor 21IBA 01/2021 - 11/2015
8	LipidsIBA 10/2022 - 11/2015
8	CalciumIBA 01/2022 - 01/2016
8	AntioxidantsIBA 08/2019 - 01/2016
7	PrebioticsIBA 12/2020 - 01/2017
6	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 06/2022 - 01/2018
6	Galactose (Galactopyranose)FDA LinkGeneric 04/2022 - 01/2018
6	humaninIBA 01/2022 - 01/2016
6	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2017
6	CholesterolIBA 06/2021 - 08/2012
6	Amyloid beta-PeptidesIBA 01/2021 - 07/2017
5	MelatoninIBA 05/2022 - 11/2018
5	Transferrin (beta 2 Transferrin)IBA 01/2022 - 08/2013
5	Atorvastatin (Lipitor)FDA Link 10/2020 - 01/2018
5	DeferiproneIBA 12/2019 - 01/2016
5	Insulin ReceptorIBA 01/2018 - 11/2011
4	Lipocalin-2IBA 01/2022 - 01/2018
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2017
4	Neuroprotective AgentsIBA 01/2022 - 01/2018
4	Indicators and Reagents (Reagents)IBA 12/2021 - 01/2015
4	Donepezil (Aricept)FDA LinkGeneric 11/2021 - 01/2021
4	Cysteine (L-Cysteine)FDA Link 12/2020 - 01/2016
4	Isoflurophate (DFP)FDA Link 03/2018 - 01/2016
3	coenzyme Q10 (CoQ10)IBA 02/2022 - 04/2018
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 11/2017
3	SodiumIBA 01/2022 - 10/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 11/2015
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2021 - 03/2010
3	Trastuzumab (Herceptin)FDA Link 07/2021 - 01/2020
3	oxidized low density lipoproteinIBA 06/2021 - 01/2019
3	Bevacizumab (Avastin)FDA Link 01/2021 - 02/2015
3	necrostatin-1IBA 01/2021 - 01/2020
3	Malondialdehyde (Propanedial)IBA 10/2020 - 01/2016
3	xylooligosaccharideIBA 06/2020 - 10/2018
3	dapagliflozinIBA 01/2020 - 10/2017
3	efonidipineIBA 12/2019 - 04/2016

Therapy/Procedure

31	Therapeutics 05/2022 - 06/2014
11	Drug Therapy (Chemotherapy) 01/2022 - 02/2015
6	Vagus Nerve Stimulation 01/2022 - 10/2014
5	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2017
4	Glycemic Control 01/2018 - 10/2015